Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma

por Ahn, Stephen, Park, Jae‐Sung, Kim, Heewon, Heo, Minkyu, Sung, Young Chul, Jeun, Sin‐Soo
Publicado 2022

hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects

por Lee, Sang Won, Choi, Donghoon, Heo, MinKyu, Shin, Eui‐Cheol, Park, Su‐Hyung, Kim, So Jeong, Oh, Yeon‐Kyung, Lee, Byung Ha, Yang, Se Hwan, Sung, Young Chul, Lee, Howard
Publicado 2020

A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions

por Kim, Sojeong, Lee, Sang Won, Koh, June-Young, Choi, Donghoon, Heo, Minkyu, Chung, Jae-Yong, Lee, Byung Ha, Yang, Se Hwan, Sung, Young Chul, Lee, Howard, Shin, Eui-Cheol, Park, Su-Hyung
Publicado 2022

SAT-LB15 24-Month Efficacy and Safety of Once Weekly and Every Other Week Administration of GX-H9, Hybrid FC-Fused Long-Acting Human Growth Hormone: A Phase 2 Study in Children Wit...

por Malievskiy, Oleg, Mykola, Aryaev, Zelinska, Nataliya, Bolshova, Elena, Senatorova, Ganna, Oroszlán, György, Skorodok, Julia, Peterkova, Valentina, Chorna, Nataliya, Sorokman, Tamila, Yang, Seung, Lee, Ji-Eun, Muzsnai, Agota, Hwang, Jin Soon, Lee, Sang-Yoon, Son, HyunJoo, Heo, SuJin, Heo, Minkyu, Choi, Yun Jung, Sung, Young Chul
Publicado 2020